Chris Schneider Takes on Senior Level Strategy Role at Ipsos Healthcare


Forecasts Stronger Insights for Pharma Companies

New York, NY August 15, 2013– research expert has joined Ipsos Healthcare as Senior Vice President, Commercial and Forecasting.
Chris Schneider

“With a background in both research firms and pharmaceutical companies, Chris brings a wealth of expertise to our team, with a holistic view of what our clients need and what we can help them achieve,” says Elys Roberts, President of Ipsos Healthcare, North America. “In his at Ipsos Healthcare, Chris will help our clients identify new opportunities, assess the value of new assets, define their strategies, and plan for the future. And he will be supported by one of the largest and fastest growing teams in our industry. I’m pleased to welcome Chris to our team.”

Chris Schneider brings more than 12 years of broad BioPharma experience from a variety of commercial strategy and analytical roles on both the client and agency sides of the business.

In his most recent role prior to joining Ipsos, Schneider led diverse teams of qualitative and quantitative market researchers at another healthcare market research agency and before that, spent 10 years on the client-side of the industry at Roche and Pfizer in roles within strategic pricing and customer development, business development/licensing, and finance.

“Given the rapid evolution of the BioPharma environment in which our clients operate, true business insight is more important than ever,” says Schneider. “I’m delighted to be part of the Ipsos Healthcare team, helping our clients make better commercial decisions by harnessing the strength of Ipsos’ world-class research and syndicated data and providing a clear view of our clients’ customers, their market dynamics and how to bring clarity and optimize brand performance in this complex multi-stakeholder environment.”

Chris Schneider’s market research and commercial strategy…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS